Rabies is a deadly viral infection that attacks the central nervous system, affecting mammals, including humans.
It is almost always fatal once clinical symptoms appear, but it is 100% preventable with prompt medical care after potential exposure.
The virus is most commonly transmitted through the saliva of an infected animal, usually via a bite or scratch.
Post-Exposure Prophylaxis (PEP): If an animal bite or scratch is suspected, immediate treatment is crucial and can prevent the disease from developing.
This involves administering a 1 ml dose in the upper arm (deltoid) on multiple days.
5-dose schedule: Days 0, 3, 7, 14, and 28.
This is for people at high risk of exposure, such as animal handlers, veterinarians, or travelers to endemic areas.
Schedule: One full dose is administered either intramuscularly or intradermally on days 0, 7, and either 21 or 28.
Abhayrab: From Indian Immunologicals Ltd. (IIL), a prominent Indian vaccine manufacturer.
Rabivax-S: Produced by Serum Institute of India, one of the world's largest vaccine manufacturers.
Vaxirab N: From Zydus Cadila.
Verorab: Manufactured by Sanofi Pasteur.
In cases of severe bites, rabies immunoglobulin (RIG) is given to provide immediate, temporary immunity. The following brands are also available in India.
Equirab: An Equine Rabies Immunoglobulin (ERIG) made by Bharat Serums & Vaccines Ltd..
Rabishield: The world's first rabies monoclonal antibody (RmAb), developed and launched by Serum Institute of India